Andrew Babiskin, Ph.D.

US Food and Drug Administration

Poster(s):

• (T1330-04-26) Effect of Omeprazole Administration on the Pharmacokinetics of Oral Extended-Release Nifedipine: Physiologically Based Pharmacokinetic Modeling
  Tuesday, October 24, 2023

  1:30 PM – 2:30 PM ET

• (T1030-10-66) Identifying Critical Parameters for Physiological Based Pharmacokinetic Modeling of Naloxone Hydrochloride Nasal Sprays
  Tuesday, October 24, 2023

  10:30 AM – 11:30 AM ET

• (T1530-12-78) Preclinical Evaluation of Brinzolamide Ophthalmic Suspensions with Variations in Critical Quality Attributes and Considerations for Pharmacokinetic/Pharmacodynamic Study Designs
  Tuesday, October 24, 2023

  3:30 PM – 4:30 PM ET